Fibromyalgia

Fibromyalgia: What Is the Research Revealing?

Fibromyalgia can affect nearly every part of life—widespread pain, fatigue, poor sleep, brain fog, and a sensitivity to pain that can make even ordinary activities difficult. And for many people, finding lasting relief can be frustratingly difficult.

That is why some of the emerging research in regenerative medicine is so interesting.

Researchers are discovering that fibromyalgia may involve much more than pain alone. Recent research has found complex relationships among immune signaling, cytokines and chemokines, muscle tissue, adipose tissue, and the peripheral and central nervous systems—including measurable biological factors associated with pain intensity and pain sensitivity.

This is one reason researchers are investigating whether regenerative approaches may influence some of these underlying biological pathways.

Here’s a glimpse of what you’ll find in our research collection:

Cell signaling and chronic pain

Research on mesenchymal stromal cells suggests their potential effects may extend beyond the cells themselves. Scientists are studying the growth factors, extracellular vesicles and other signals released by these cells and how they may influence inflammation, nerve function and pain signaling.

Fibromyalgia and inflammation

A 2024 human study found distinct patterns of cytokines and chemokines in people with fibromyalgia and found relationships between these biological markers and pain intensity, pain sensitivity, muscle characteristics and fat infiltration. The researchers concluded that fibromyalgia appears to involve complex interactions among peripheral tissues, the immune system, and the central and peripheral nervous systems.

What happens in experimental models?

Animal research is investigating whether regenerative cells can influence inflammatory pathways involved in fibromyalgia-like pain. One study, for example, found changes involving the NLRP3 inflammasome and neurobiological pathways after mesenchymal stromal cell treatment. This is early, preclinical evidence—not proof of what will happen in people—but it helps researchers understand how these therapies might work. The research is moving beyond the cells themselves.

Studies of extracellular vesicles and exosomes are examining how microscopic “messages” released by regenerative cells may affect inflammation, nerve signaling and chronic pain. This is an especially active area of regenerative research.

And what are clinics actually seeing?

Some regenerative medicine clinics report patients experiencing meaningful reductions in pain along with improvements in fatigue, stiffness, sleep and overall function. Reported timing varies—from changes beginning within several weeks to improvements continuing to develop over several months. These are clinical observations rather than controlled trial results, and individual responses vary. That distinction matters.

Request the Complimentary Fibromyalgia Research Collection

We’ll send you selected research with brief explanations of what each study investigated, what the researchers found, and links to the original publications.

You’ll see the encouraging findings—but also the limitations and unanswered questions.

Think of it as a springboard for your own research and conversations with your healthcare provider.

You don't have to decide that regenerative medicine is the answer. But before deciding that there is nothing more to explore, shouldn't you know what researchers are investigating?

→ Request Our Complimentary Fibromyalgia Regenerative Research Collection